NUTM2B and submandibular gland neoplasm: The one recently reported case (4.2 cm NFATC2::NUTM2B fused submandibular gland tumor in a 68‐year‐old male, reported as carcinoma with myoepithelial features and treated by surgery + adjuvant radiotherapy) had an uneventful course at 20 months follow‐up [15].